Navigation Links
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Date:3/14/2008

acne and burns.

About Isolagen, Inc.

Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic company committed to developing and commercializing scientific advances and innovative technologies. The company's technology platform includes the Isolagen Process(TM), a cell processing system for skin and tissue rejuvenation which is currently in clinical development for a broad range of aesthetic and therapeutic applications including wrinkles, acne scars, burns and periodontal disease. Isolagen also commercializes a scientifically-advanced line of skincare systems through its majority-owned subsidiary, Agera(R) Laboratories, Inc. For additional information, please visit http://www.isolagen.com .

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release, include, without limitation, the timely completion of the study injections, the timely completion of the overall acne study, the timely completion of the Company's Phase III wrinkle study, and the Company's ability to raise additional funding, whether through strategic partners for outlicensing, by selling its Swiss facility, or otherwise. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward- looking statements rely on a number of assumpti
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
2. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
3. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
4. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
5. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
6. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
7. Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
8. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
9. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
10. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... WORTH, Texas , April 27, 2015 ... market is segmented based on type, application, and geography and ... at $728.9 million in 2014, and is expected to reach ... the forecast period. Browse through the TOC of ... idea of the in-depth analysis provided. This also provides a ...
(Date:4/27/2015)... April 27, 2015  Eiger BioPharmaceuticals, Incorporated today announced ... of lonafarnib in patients with chronic hepatitis delta viral ... program, enrolled at Ankara University Medical School, ... endemic. LOWR HDV - 1 (LOnafarnib ... study which randomized subjects to receive different doses of ...
(Date:4/27/2015)... NEW YORK , April 27, 2015 /PRNewswire/ ... market for electronic medical records (EMR) to grow ... for US healthcare providers, according to a recent ... system upgrades, international sales and continued efficiency improvements ... each year for the next five years.  The ...
Breaking Medicine Technology:North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 2North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 3Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3
... , WALTHAM, Mass., Dec. 15 Decision Resources, one of ... healthcare issues, finds that an overall survival benefit would be ... in their decision to prescribe a novel agent ahead of ... Special European Physician & Payer Forum report entitled European ...
... BEND, Oregon, December 15 Bend Research Inc. ... for HPMCAS, an,excipient used in technologies developed by the firm to ... Bend Research clients may now reference a Type V Drug ... Research officials said. , "We,re excited about ...
Cached Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2
(Date:4/27/2015)... (PRWEB) April 27, 2015 Diamond reflective ... unneeded risk of damaging hot spots. , Gorilla Grow ... because of their sturdy structure and strong material that ... was design to effectively distribute lumens and eliminates hot ... most benefit from grow lights and produces the highest ...
(Date:4/27/2015)... Array Health , a leading provider ... Lance Hood, senior director of marketing, will participate in ... Health Care Marketing Summit on April 29, 2015. ... Director of Payer Services, Leavitt Partners, LLC, will address ... a retail/e-commerce perspective – and equip attendees with the ...
(Date:4/27/2015)... According to a recent report from NIDCR (National ... pain, TMJ disorders are the second most prevalent ... addition, the report revealed that TMJ disorders affect about ... estimated 4 billion dollars annually. , These estimates suggest ... symptoms such as headaches, neck pain, tenderness of the ...
(Date:4/27/2015)... Ticket Down is a reputable source of ... his upcoming concert on Sunday, June 21st. , Paul McCartney, ... North American fans again in 2015 when he goes out ... tour. He will be performing in some cities overseas ... this legendary performer for the first time in 5 years. ...
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 Beckman ... “Using Next-Gen sequencing to study the evolution of neural ... Senatore, which will review the mechanisms by which analogous ... left-right (LR) body flexions, evolved independently in certain sea ... will be broadcast live April 30, 2015 at 8:00am ...
Breaking Medicine News(10 mins):Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3
... -- While there are challenges, Halloween can still be fun ... enjoy Halloween and enjoy some of the sweets the holiday ... and senior scientist at the University of Alabama at Birmingham ... "We give parents and kids three options and let them ...
... Postmenopausal women who gained weight during adulthood had ... who maintained a stable weight, according to data from ... Cohort. Victoria L. Stevens, Ph.D., strategic director ... the American Cancer Society in Atlanta, presented the data ...
... Cancer Institute (HCI) at the University of Utah have discovered ... lead to new tools for predicting which breast cancers will ... its spread. Their results are published online today in the ... model for breast cancer studies, the researchers grafted tumor tissue ...
... are headed for the economic stratosphere, even as researchers come ... to earth. An assessment of the growing problem and ... dealing with heart failure patients when they present to emergency ... the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and ...
... Cardiac rehabilitation boosts longevity, especially in patients with the ... Canadian Cardiovascular Congress 2011, co-hosted by the Heart and ... are benefits to cardiac rehabilitation, regardless of how fit ... a cardiac surgery resident and PhD candidate at the ...
... , SATURDAY, Oct. 22 (HealthDay News) -- Marathons place heavy ... measures to ensure they stay healthy and are able to ... Runners need enough energy to perform at their best and ... Loyola University Health System. She offered a simple guideline for ...
Cached Medicine News:Health News:Healthy Halloween Advice for Children With Diabetes 2Health News:Significant weight gain in adulthood increased risk for endometrial cancer 2Health News:Will my breast cancer spread? Discovery may predict probability of metastasis 2Health News:Billions of dollars at stake as Canada comes to grips with soaring heart failure costs 2Health News:Billions of dollars at stake as Canada comes to grips with soaring heart failure costs 3Health News:Billions of dollars at stake as Canada comes to grips with soaring heart failure costs 4Health News:Rehab helps heart patients live longer -- but they have to show up 2Health News:Rehab helps heart patients live longer -- but they have to show up 3Health News:Nutrition, Hydration Tips Can Give Marathon Runners a Leg Up 2
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured hemi-ball tip...
Vaulted shank with guard....
... Keeler ophthalmoscopes are individually adjusted for ... the eye, not on paper. This, along ... infinity focus, ensures that whatever the patient's ... and largest field of view. Lithium-ion technology ...
Medicine Products: